Department of Neurosurgery, Weill Cornell Medicine, New York-Presbyterian Hospital, 525 East 68th St., Box #99, New York, NY, 10065, USA.
Department of Neurosurgery, Columbia University Medical Center, New York-Presbyterian Hospital, New York, NY, USA.
Acta Neurochir (Wien). 2021 Jan;163(1):101-112. doi: 10.1007/s00701-020-04552-x. Epub 2020 Sep 5.
Olfactory groove meningiomas (OGMs) are commonly treated with open craniotomy. Endonasal approaches have also been described.
To present clinical and radiographic outcomes for the minimally invasive eyebrow incision supraorbital keyhole approach with endoscopic assistance for OGMs.
We performed a retrospective single-center cohort study and a systematic literature review.
Fifteen patients were identified, all with Grade I meningiomas. Radiographic gross total resection of enhancing tumor was achieved in all patients. Mean frontal lobe fluid-attenuated inversion recovery volume decreased from 11.1 ± 18.3 cm preoperatively to 9.9 ± 11.4 cm immediately postoperatively, and there was minimal new restricted diffusion (3.2 ± 2.2 cm; max 7.5 cm). Median length of stay was 3 days (range 2-8). Vision was improved in 4 (80%) and stable in 1 (20%) of 5 patients with a preoperative deficit. New postoperative anosmia occurred in 3 (23%) of 13 patients with any preoperative olfaction. All patients were satisfied with their cosmetic result at 3 months. After a median follow-up of 32.2 months, there were 2 (13.3%) asymptomatic radiographic recurrences, 1 treated with radiosurgery and the other with endoscopic endonasal approach (EEA). No patients required further craniotomy. Systematic review revealed the present series to be the largest to date reporting disaggregated outcomes for the eyebrow approach to OGM.
The eyebrow incision supraorbital keyhole craniotomy with endoscopic assistance is a safe and effective approach to OGM with tumor control rates similar to more invasive open approaches and better than the endonasal approach. Rates of frontal lobe injury, CSF leak and anosmia are comparatively low.
嗅沟脑膜瘤(OGM)通常采用开颅手术治疗。也有经鼻内镜入路的报道。
介绍经眉弓眶上额下入路内镜辅助治疗 OGM 的微创方法,并报告其临床和影像学结果。
我们进行了回顾性单中心队列研究和系统文献复习。
共纳入 15 例患者,均为 I 级脑膜瘤。所有患者均实现了增强肿瘤的大体全切除。平均额叶 FLAIR 容积从术前的 11.1±18.3cm 减少到术后即刻的 9.9±11.4cm,且新出现的弥散受限极小(3.2±2.2cm,最大 7.5cm)。中位住院时间为 3 天(范围 2-8 天)。术前存在视力缺损的 5 例患者中,4 例(80%)视力改善,1 例(20%)稳定。术前嗅觉正常的 13 例患者中有 3 例(23%)出现新的术后嗅觉丧失。所有患者在术后 3 个月对美容效果均满意。中位随访 32.2 个月后,2 例(13.3%)出现无症状的影像学复发,1 例接受了放射外科治疗,另 1 例接受了内镜经鼻入路(EEA)治疗。无患者需要再次开颅手术。系统综述显示,本研究是迄今为止报告眉弓入路治疗 OGM 结果的最大系列研究。
经眉弓眶上额下入路内镜辅助手术是一种安全有效的治疗 OGM 的方法,其肿瘤控制率与更具侵袭性的开颅手术相似,优于经鼻内镜入路。额叶损伤、CSF 漏和嗅觉丧失的发生率较低。